These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Complications and limitations of drug therapy for Parkinson's disease. Jankovic J Neurology; 2000; 55(12 Suppl 6):S2-6. PubMed ID: 11188970 [TBL] [Abstract][Full Text] [Related]
4. [Updates in practical neurology--I. The principles of modern levodopa therapy in Parkinson's disease]. Klivényi P; Vécsei L Ideggyogy Sz; 2007 Jan; 60(1-2):61-4. PubMed ID: 17432097 [TBL] [Abstract][Full Text] [Related]
5. Psychiatric disturbances occurring during levodopa therapy of Parkinson's disease. Lloyd KG Prim Care; 1977 Sep; 4(3):561-75. PubMed ID: 264230 [TBL] [Abstract][Full Text] [Related]
7. Neuropsychological findings in Parkinson's disease: a comparison between various tests during long-term levodopa therapy. Botez MI; Barbeau A Int J Neurol; 1975; 10(1-4):222-32. PubMed ID: 1181311 [No Abstract] [Full Text] [Related]
8. Levodopa-related motor complications--phenomenology. Fox SH; Lang AE Mov Disord; 2008; 23 Suppl 3():S509-14. PubMed ID: 18781677 [TBL] [Abstract][Full Text] [Related]
9. Treatment strategies in Parkinson's disease after a quarter century experiences with L-DOPA therapy. Fischer PA J Neural Transm Suppl; 1995; 46():381-9. PubMed ID: 8821073 [TBL] [Abstract][Full Text] [Related]
10. Levodopa in the early treatment of Parkinson's disease. Murata M Parkinsonism Relat Disord; 2009 Jan; 15 Suppl 1():S17-20. PubMed ID: 19131036 [TBL] [Abstract][Full Text] [Related]
12. [L-dopa in the therapy of Parkinson's disease today]. Piccinin GL; Piccirilli M; Morocutti C Clin Ter; 1982 Jan; 100(2):189-202. PubMed ID: 6764620 [No Abstract] [Full Text] [Related]
13. High-level levodopa therapy in Parkinson's disease: five years later. Barbeau A Trans Am Neurol Assoc; 1974; 99():160-3. PubMed ID: 4463526 [No Abstract] [Full Text] [Related]
14. Initial therapy for Parkinson's disease: levodopa vs. dopamine receptor agonists. Kondo T J Neurol; 2002 Sep; 249 Suppl 2():II25-9. PubMed ID: 12375060 [TBL] [Abstract][Full Text] [Related]
15. Problems with long-term levodopa therapy for Parkinson's disease. Marsden CD Clin Neuropharmacol; 1994; 17 Suppl 2():S32-44. PubMed ID: 9358193 [TBL] [Abstract][Full Text] [Related]
16. Does levodopa therapy delay death in Parkinson's disease? Uitti RJ; Ahlskog JE; Maraganore DM Mov Disord; 1996 May; 11(3):343-4. PubMed ID: 8723162 [No Abstract] [Full Text] [Related]
17. [Multivariate analysis of the problems of long-term levodopa therapy in Parkinson's disease]. Nakamura Y; Yoshinaga J; Endo S; Hikiji A Rinsho Shinkeigaku; 1997 Jun; 37(6):469-75. PubMed ID: 9366172 [TBL] [Abstract][Full Text] [Related]
18. Early combination therapy with bromocriptine and levodopa in Parkinson's disease. Factor SA; Weiner WJ Mov Disord; 1993 Jul; 8(3):257-62. PubMed ID: 8341289 [TBL] [Abstract][Full Text] [Related]
20. The hypothesis of the genesis of motor complications and continuous dopaminergic stimulation in the treatment of Parkinson's disease. Stocchi F Parkinsonism Relat Disord; 2009 Jan; 15 Suppl 1():S9-S15. PubMed ID: 19131046 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]